A mechanism of AZT resistance: An increase in nucleotide-dependent primer unblocking by mutant HIV-1 reverse transcriptase

Molecular Cell

Volumn 4, Issue 1, 1999, Pages 35-43

  Meyer, Peter R ^a   Matsuura, Suzanne E ^a   Mohsin Mian, A ^a   So, Antero G ^a   Scott, Walter A ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; RNA DIRECTED DNA POLYMERASE; VIRUS ENZYME; ZIDOVUDINE;

ARTICLE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME PURIFICATION; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0033165851     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(00)80185-9     Document Type: Article

References (29)

1. Arion, D., Kaushik, N., McCormick, S., Borkow, G., and Parniak, M.A. (1998). Phenotypic mechanism of HIV-1 resistance to 3′-azido-3′-deoxythymidine (AZT): Increased polymerization processivity and enhanced sensitivity to pyrophosphate of the mutant viral reverse transcriptase. Biochemistry 37, 15908-15917.
2. Battula, N., and Loeb, L.A. (1976). On the fidelity of DNA replication. Lack of exodeoxyribonuclease activity and error-correcting function in avian myeloblastosis virus DNA polymerase. J. Biol. Chem. 251, 982-986.
3. Bochner, B.R., and Ames, B.N. (1982). Complete analysis of cellular nucleotides by two-dimensional thin layer chromatography. J. Biol. Chem. 257, 9759-9769.
4. Canard, B., Sarfati, S.R., and Richardson, C.C. (1998). Enhanced binding of azidothymidine-resistant human immunodeficiency virus 1 reverse transcriptase to the 3′-azido-3′-deoxythymidine 5′-monophosphate-terminated primer. J. Biol. Chem. 273, 14596-14604.
5. Carroll, S.S., Geib, J., Olsen, D.B., Stahlhut, M., Shafer, J.A., and Kuo, L.C. (1994). Sensitivity of HIV-1 reverse transcriptase and its mutants to inhibition by azidothymidine triphosphate. Biochemistry 33, 2113-2120.
6. Cheng, Y.-C., Dutschman, G.E., Bastow, K.F., Sarngadharan, M.G., and Ting, R.Y.C. (1987). Human immunodeficiency virus reverse transcriptase. General properties and its interactions with nucleoside triphosphate analogs. J. Biol. Chem. 262, 2187-2189.
7. Emini, E.A., and Fan, H.Y. (1997). Immunological and pharmacological approaches to the control of retroviral infections. In Retroviruses, J.M. Coffin, S.H. Hughes, and H.E. Varmus, eds. (Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press), pp. 637-706.
8. Furman, P.A., Fyfe, J.A., St. Clair, M.H., Weinhold, K., Rideout, J.L., Freeman, G.A., Nusinoff-Lehrman, S., Bolognesi, D.P., Broder, S., Mitsuya, H., and Barry, D.W. (1986). Phosphorylation of 3′-azido-3′-deoxythymidine and selective interaction of the 5′-triphosphate with human immunodeficiency virus reverse transcriptase. Proc. Natl. Acad. Sci. USA 83, 8333-8337.
9. Hauschka, P.V. (1973). Analysis of nucleotide pools in animal cells. Methods Cell Biol. 7, 361-462.
10. Hsieh, J.-C., Zinnen, S., and Modrich, P. (1993). Kinetic mechanism of the DNA-dependent DNA polymerase activity of human immunodeficiency virus reverse transcriptase. J. Biol. Chem. 268, 24607-24613.
11. Huang, P., Farquhar, D., and Plunkett, W. (1990). Selective action of 3′-azido-3′-deoxythymidine 5′-triphosphate on viral reverse transcriptases and human DNA polymerases. J. Biol. Chem. 265, 11914-11918.
12. Huang, H., Chopra, R., Verdine, G.L., and Harrison, S.C. (1998). Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: Implications for drug resistance. Science 282, 1669-1675.
13. Kerr, S.G., and Anderson, K.S. (1997). Pre-steady-state kinetic characterization of wild type and 3′-azido-3′-deoxythymidine (AZT) resistant human immunodeficiency virus type 1 reverse transcriptase: Implication of RNA directed DNA polymerization in the mechanism of AZT resistance. Biochemistry 36, 14064-14070.
14. Krebs, R., Immendörfer, U., Thrall, S.H., Wöhrl, B.M., and Goody, R.S. (1997). Single-step kinetics of HIV-1 reverse transcriptase mutants responsible for virus resistance to nucleoside inhibitors zidovudine and 3-TC. Biochemistry 36, 10292-10300.
15. Lacey, S.F., Reardon, J.E., Furfine, E.S., Kunkel, T.A., Bebenek, K., Eckert, K.A., Kemp, S.D., and Larder, B.A. (1992). Biochemical studies on the reverse transcriptase and RNase H activities from human immunodeficiency virus strains resistant to 3′-azido-3′-deoxythymidine. J. Biol. Chem. 267, 15789-15794.
16. Larder, B.A., Darby, G., and Richman, D.D. (1989). HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science 243, 1731-1734.
17. Larder, B.A., Chesebro, B., and Richman, D.D. (1990). Susceptibilities of zidovudine-susceptible and -resistant human immunodeficiency virus isolates to antiviral agents determined by using a quantitative plaque reduction assay. Antimicrob. Agents Chemother. 34, 436-441.
18. Meyer, P.R., Matsuura, S.E., So, A.G., and Scott, W.A. (1998). Unblocking of chain-terminated primer by HIV-1 reverse transcriptase through a nucleotide-dependent mechanism. Proc. Natl. Acad. Sci. USA 95, 13471-13476.
19. Mitsuya, H., Yarchoan, R., and Broder, S. (1990). Molecular targets for AIDS therapy. Science 249, 1533-1544.
20. Munir, K.M., French, D.C., Dube, D.K., and Loeb, L.A. (1992). Permissible amino acid substitutions within the putative nucleoside-binding site of herpes simplex virus type 1 established by random sequence mutagenesis. J. Biol. Chem. 267, 6584-6589.
21. Reardon, J.E. (1993). Human immunodeficiency virus reverse transcriptase. A kinetic analysis of RNA-dependent and DNA-dependent DNA polymerization. J. Biol. Chem. 268, 8743-8751.
22. Ren, J., Esnouf, R.M., Hopkins, A.L., Jones, E.Y., Kirby, I., Keeling, J., Ross, C.K., Larder, B.A., Stuart, D.I., and Stammers, D.K. (1998). 3′-Azido-3′-deoxythymidine drug-resistance mutations in HIV-1 reverse transcriptase can induce long range conformational changes. Proc. Natl. Acad. Sci. USA 95, 9518-9523.
23. Roberts, J.D., Bebenek, K., and Kunkel, T.A. (1988). The accuracy of reverse transcriptase from HIV-1. Science 242, 1171-1173.
24. Sarkar, G., and Sommer, S.S. (1990). The "megaprimer" method of site-directed mutagenesis. BioTechniques 8, 404-407.
25. 4N counterparts as substrates of firefly luciferase, dinucleoside tetraphosphatase and phosphodiesterases. Biochim. Biophys. Acta 1334, 191-199.
26. St. Clair, M.H., Richards, C.A., Spector, T., Weinhold, K.J., Miller, W.H., Langlois, A.J., and Furman, P.A. (1987). 3′-azido-3′-deoxythymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptase. Antimicrob. Agents Chemother. 31, 1972-1977.
27. Tan, C.-K., Zhang, J., Li, Z.-Y., Tarpley, W.G., Downey, K.M., and So, A.G. (1991). Functional characterization of RNA-dependent DNA polymerase and RNase H activities of a recombinant HIV reverse transcriptase. Biochemistry 30, 2651-2655.
28. Tong, W., Lu, C.-D., Sharma, S.K., Matsuura, S., So, A.G., and Scott, W.A. (1997). Nucleotide-induced stable complex formation by HIV-1 reverse transcriptase. Biochemistry 36, 5749-5757.
29. Ueno, T., and Mitsuya, H. (1997). Comparative enzymatic study of HIV-1 reverse transcriptase resistant to 2′-3′-dideoxynucleotide analogs using the single-nucleotide incorporation assay. Biochemistry 36, 1092-1099.